Looking at the road ahead to properly utilizing digital technology in clinical trials.
Aman Khera
Advertisement
VP, Global Head of Regulatory Strategy, Worldwide Clinical Trials
Articles by Aman Khera
Roadmap of twists and turns that lie ahead following most recent draft issued in September.
The COVID-19 pandemic has pushed several focus areas to the forefront of the industry.
Findings from the most recent Biopharma Confidence Index show that the pandemic has substantially influenced biopharma executives’ expectations in key areas like artificial intelligence/machine learning and real-world evidence.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
When There’s No Registry: Building Rare Disease Evidence That Supports Regulatory Scrutiny
2
ACT Brief: Patient-Site Trust Barriers, Rare Disease Evidence Without Registry, and RWD Enrollment Accuracy
3
Moving Beyond Disappointing Pilots: Scaling Adoption of AI-Enablement in Drug Development
4
Trust, Technology, and the Patient-Site Relationship: Q&A with Andrea Valente, uMotif
5